Abstracts
Showing 807 abstracts.
Long-term metabolic implications of initiating lopinavir/ritonavir-based regimens for infants and children: a follow-up study of IMPAACT P1060
Conference
IAS 2017
Study
P1060
Authors
M Hernan, K Angelidou, G Aldrovandi, P Palumbo for the IMPAACT P1060 Study Team, K Patel, J LindseyPharmacokinetics of Rifampin and Isoniazid during Pregnancy and Postpartum in South African Women
Conference
IAS 2017
Study
P1026S
Authors
E Decloedt, GB Theron, MF Cotton, B Best, E Capparelli, A Stek, J Wang, M Mirochnick on behalf of the IMPAACT P1026s Protocol team, M Van Schalkwyk, A BekkerOutcomes of second-line antiretroviral therapy (ART) in HIV-infected children: a CIPHER cohort collaboration global analysis
Conference
IAS 2018
Study
P1074
Authors
IJ Collins, CIPHER Cohort Collaboration Duration of Second-line Proi, R BGoodall, E Abrams, A Sohn, T Mohamed, R Van Dyke, P Rojo, K Wools-Kaloustian, J Pinto, A Edmonds, I Marete, M Paul, H Nuwaqaba-Biribonwoha, V Leroy, K Patel, M-A Davies, B Simth, R VreemanIntracellular concentrations of tenofovir diphosphate (TFV-DP) during pregnancy in the PROMISE study: Description and relationship with adverse pregnancy outcomes
Conference
IAS 2018
Study
1077BF
Authors
M Mirochnick, P Flynn, M Cababasay, JJ Kiser, G Siberry, T Fenton, K Butler, MG Fowler, PROMISE study team, J Aizire, KM BrooksIMPAACT P1110: Raltegravir pharmacokinetics and safety in HIV-1 exposed neonates: Dose-finding study in infants born to mothers receiving raltegravir-containing ART
Conference
IAS 2018
Study
P1110
Authors
A Chain, M Cababasay, J Wang, H Teppler, E Smith, R Hazra, S Popson, B Graham, K Calabrese, Y Bryson , S Spector, M Mirochnick, D Clarke, E AcostaPharmacokinetic and 4-week safety/efficacy of dolutegravir (S/GSK1349572) dispersible tablets in HIV-infected children aged 4 weeks to < 6 years: Results from IMPAACT P1093
Conference
IAS 2018
Study
P1093
Authors
R Singh, C Alvero, T Fenton, K George, S Popson, E Townley, R Hazra, C Brothers, C Vavro, A Buchanan, A Wiznia, IMPAACT P1093 team, T Ruel, E AcostaPharmacokinetics of darunavir boosted with cobicistat during pregnancy and postpartum
Conference
IAS 2018
Study
P1026S
Authors
J Wang, A Stek, DE Shapiro, K George, E Barr, K Rungruengthanakit, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick, J Momper, B BestTenofovir alafenamide pharmacokinetics with and without cobicistat in pregnancy
Conference
CROI 2018
Study
P1026S
Authors
J Wang, A Stek, TR Cressey, S Burchett, R Kreitchmann, DE Shapiro, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick, IMPAACT P1026s Protocol team, JD Momper, B BestPharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
Conference
IAS 2019
Study
P1092
Authors
L Ziemba, A Coletti, R Browning, R Aweeka, J Moye, P Musoke, B Graham, C Reding, D Costello, J Norman, L Wiesner, E Hughes, M Whalen, L Purdue, BT Mmbaga, P Kamthunzi, R Kawalazira, M Owor, K Nathoo, C Tierney, S BradfordInteraction between etonogestrel-releasing implant and 3 antiretroviral regimens
Conference
CROI 2017
Study
P1026S